EAACI Congress 2023
BackAllergen immunotherapy
Friday 09 Jun, 12:00 PM -
13:00 PM CEST
Poster Zone A
Posters
12:00
Adherence to pre-seasonal short-term subcutaneous immunotherapy versus perennial sublingual immunotherapy over 3 years of treatment: real-world data for MCT (MicroCrystalline Tyrosine) associated pollen allergoids
12:00
An innovative approach to cultural dissemination about AIT for young residents in Allergology and Clinical Immunology in Italy
12:00
Cow's milk immunotherapy
12:00
Designing Hypoallergenic Variants of Ara h 1 and Ara h 2 for Safer and Effective Immunotherapy
12:00
Early manifestation of effective allergen-specific immunotherapy (ASIT) in children
12:00
Healthcare resource utilisation in patients treated with sublingual liquid immunotherapy for allergic rhinitis in real practice: results from the EfficAPSI study
12:00
Impact of sublingual immunotherapy on asthma onset in patients with allergic rhinitis: results from the EfficAPSI study
12:00
Increased Respiratory Effort(RE) during sleep as an early indicator of allergic rhinitis to Alternaria Alternata decreases after sublingual Immunotherapy (SLIT) to Alternaria Alternata. Sleep disorders resolve along to the decrease of the RE during sleep
12:00
Modalities of use of sublingual allergen immunotherapy in routine clinical practice: preferences, adherence and satisfaction. Results from the observational, prospective, longitudinal study PRACTIS
12:00
Oral immunotherapy impacts the immunological and metabolic profile of peanut-allergic young children
12:00
Potential of IgE-receptor expression measurements as biomarker in hymenoptera venom allergy
12:00
Safety of subcutaneous and sublingual immunotherapy with carbamylated monomeric allergoids in children: a real-life pharmacovigilance study
